The impact of stress-induced DNA breaks on chromatin structure, gene activity, and neuron function

应激诱导的 DNA 断裂对染色质结构、基因活性和神经元功能的影响

基本信息

  • 批准号:
    10655982
  • 负责人:
  • 金额:
    $ 79.98万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-04-05 至 2028-01-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY: Chronic stress causes molecular adaptations and structural remodeling of neurons within corticolimbic brain areas, including the prefrontal cortex (PFC) and hippocampus (HPC). This is important because the PFC and HPC are integrated in brain circuits that regulate complex behaviors and cognition. Preclinical and clinical studies indicate that synapse loss and reduced connectivity in the PFC and HPC contribute to behavioral and cognitive symptoms in several psychiatric disorders, such as post-traumatic stress disorder (PTSD) and major depressive disorder (MDD). While previous reports have identified candidate genes and pathways, the molecular mechanisms that cause lasting stress-induced changes in gene activity patterns and structural remodeling in neurons remain unknown. In preliminary studies, exposing mice to chronic unpredictable stress (CUS) triggered the formation of DNA double strand breaks (DSBs) within stress-activated neurons in the PFC. Administration of the GABAA receptor agonist, diazepam, diminished both the number of stress-activated neurons and the levels of DSBs, suggesting that stress-induced DSBs are generated by activity-dependent mechanisms. Accumulating evidence indicates that neuronal activity induces the topoisomerase, topoisomerase II (Top2B) to generate DSBs and promote the transcription of an important subset of genes that mediate experience-driven synaptic changes, including early response genes (ERGs), such as Fos, Npas4, Egr1, and Arc. These results suggest that experience-dependent DSB formation could regulate stress-induced gene activity patterns and subsequent remodeling of neurons. Yet the sites of stress-induced DSBs in PFC and HPC neurons have not been mapped and how DSBs affect stress-related gene activity patterns has not been explored. Interestingly, preliminary studies revealed that recurrent and ectopic induction of Top2B-mediated DSBs in cultured neurons is sufficient to recapitulate chronic stress-induced gene expression profiles for various neuronal activity-responsive genes, including ERGs and Bdnf. Preliminary chromosome conformation capture (3C)-based experiments (3C and 4C-seq) further suggest that DSBs regulate gene activity patterns by altering chromatin topology. These observations have led to the hypothesis that recurrent DSB formation during chronic stress alters chromatin architecture at associated genes, which in turn, stabilizes stress-related gene activity patterns that trigger neuronal remodeling and synapse loss in the PFC and HPC. To test this hypothesis, the proposed studies will map genome-wide sites of CUS-induced DSBs and utilize conditional deletion of Top2b to define how DSBs affect stress-dependent changes in transcription and neuronal structure and function in PFC and HPC projection neurons. Additionally, 3C-based methods (HiChIP) will be employed to assess how DSBs affect stress-dependent changes to chromatin architecture. Together, these efforts will provide novel insights into the mechanisms driving stress-induced neuronal adaptations, and may uncover new therapeutic strategies for psychiatric disorders, such as PTSD and MDD.
项目总结:

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ram Madabhushi其他文献

Ram Madabhushi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ram Madabhushi', 18)}}的其他基金

Mechanisms regulating the formation and repair of neuronal activity-induced DNA breaks and their effects on learning behavior
神经元活动诱导的 DNA 断裂形成和修复的调节机制及其对学习行为的影响
  • 批准号:
    10376801
  • 财政年份:
    2019
  • 资助金额:
    $ 79.98万
  • 项目类别:
Mechanisms regulating the formation and repair of neuronal activity-induced DNA breaks and their effects on learning behavior
神经元活动诱导的 DNA 断裂形成和修复的调节机制及其对学习行为的影响
  • 批准号:
    10596091
  • 财政年份:
    2019
  • 资助金额:
    $ 79.98万
  • 项目类别:

相似国自然基金

Agonist-GPR119-Gs复合物的结构生物学研究
  • 批准号:
    32000851
  • 批准年份:
    2020
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
  • 批准号:
    24K12256
  • 财政年份:
    2024
  • 资助金额:
    $ 79.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
  • 批准号:
    24K19176
  • 财政年份:
    2024
  • 资助金额:
    $ 79.98万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
  • 批准号:
    10578068
  • 财政年份:
    2023
  • 资助金额:
    $ 79.98万
  • 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
  • 批准号:
    10933287
  • 财政年份:
    2023
  • 资助金额:
    $ 79.98万
  • 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
  • 批准号:
    10650593
  • 财政年份:
    2023
  • 资助金额:
    $ 79.98万
  • 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
  • 批准号:
    10649275
  • 财政年份:
    2023
  • 资助金额:
    $ 79.98万
  • 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
  • 批准号:
    10734158
  • 财政年份:
    2023
  • 资助金额:
    $ 79.98万
  • 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
  • 批准号:
    10784209
  • 财政年份:
    2023
  • 资助金额:
    $ 79.98万
  • 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
  • 批准号:
    10580259
  • 财政年份:
    2023
  • 资助金额:
    $ 79.98万
  • 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
  • 批准号:
    23K05057
  • 财政年份:
    2023
  • 资助金额:
    $ 79.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了